Virtual Pharma Companies: The Future Is Now

Virtual pharma companies are growing because the business model works. Experience and flexibility is key for CDMOs to work successfully with them.

Once considered a trend, virtual pharmaceutical companies have become a new way of life.

Given a number of continuing industry pressures — including greater diversity of pharma R&D sponsors, looming patent expirations and increased focus on outcomes-based patient care — the virtual pharmaceutical model is proving to be successful, says Tom Salus, director of sales at Metrics Contract Services.